| Name | Title | Contact Details |
|---|
Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first-in-class therapeutic is focused on improving glucagon counterregulation by inhibiting somatostatin which is dysregulated in Type 1 diabetes.
Biomerieux is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PacketDNA Inc. is a Kanata, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA).
Oncology Care Associates is a Saint Joseph, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.